Related Articles
Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer
Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells
Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene